Rollo Capital Management
Rollo Capital Management ("RCM") is a Boston-based investment firm established in January 2008 and focused on industrial sectors, with an emphasis on materials, capital goods, chemicals, technology, automotive, energy and aerospace. RCM is the manager and advisor of CIP (Change in Progress), LP, an investment partnership pursuing medium and long-term investment strategies in publicly-listed industrial companies with an emphasis on change and innovation and with a value-based philosophy. RCM is also the manager of RCV I, LLC, an investment vehicle focused on early-stage innovative companies in the areas of materials and automation. Portfolio investments include: Gelesis (NYSE: GLS), enEvolv (acquired by Zymergen; NYSE: ZY), Continuus Pharmaceuticals PanTher Therapeutics Pearl Bio (pearlbio.com).
7-day free trial · no credit card
Verified contacts
2
available on Kipplo
LinkedIn employees
1 to 10
headcount range
Open roles
—
no listings
Distinct roles
2
indexed titles
Tech stack
0
tools in use
Monthly traffic
—
organic / mo
Sign up free to see all 2 verified contacts at Rollo Capital Management
Free for 7 days · 50 credits · no card · only pay for verified records.
Decision-makers and verified team members
2 contacts with verified email or phone · masked until revealed.
Showing 1 of 2 verified contacts
Top roles at Rollo Capital Management
2 distinct titles indexed · top 2 shown.
- 1director de desarrollo empresarial
- 1founder, owner
Sign up to unlock all 2 contacts at Rollo Capital Management
Free for 7 days · 50 credits · no card · only pay for verified records.
Sign up to reveal 2 verified contacts at Rollo Capital Management
7-day trial · no credit card · cancel anytime · only pay for verified records.
Trusted by sales, marketing, and GTM engineering teams.